Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
AlphaMa logo — AlphaMa is a pioneering drug R&D company based on AI and DEL...

AlphaMa

AlphaMa is a pioneering drug R&D company based on AI and DEL drug discovery innovation platform.

China Suzhou, China 7 employees

General Information

Company Name AlphaMa
Location China Suzhou, China +1
Employees 7
Social

Get notified when AlphaMa moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AlphaMa

AlphaMa is a pioneering drug R&D company based in Suzhou, China, established in 2018. With artificial intelligence (AI) as the driving technology, DNA-encoded library (DEL) technology is cross-applied to establish a cutting-edge Intelligent DEL (iDEL) platform(including the first-class technology of on-demand DEL synthesis, DEL screening, hit confirmation, macrocyclic peptide DELs, customized glue library, etc.). The iDEL platform at AlphaMa features first-class DNA-encoded library (DEL) technology specializing in small molecule, macrocyclic peptide and covalent hit discovery, etc. With its mature screening technology and high success rate, providing global partners with a cost-effective and efficient one-stop DEL screening service. Our flexible service model, diversified services and excellent service system cover all stages of early drug discovery. We provide flexible and cost-effective approaches to meet customers' diverse needs with professional technology and high-quality services. AlphaMa is your ideal partner for drug discovery, assisting you in accelerating the drug discovery process. Reach out to learn more: [email protected]

No funding data available for AlphaMa yet.

Get notified when AlphaMa raises funding

AlphaMa Alternatives & Competitors

AlphaMa vs
DyNAbind GmbH
DyNAbind GmbH Germany

Accelerating Drug Discovery

Seed
8 employees
Biopharma, Biotechnology
AlphaMa vs
HitGen Inc.
HitGen Inc. China

Novel Molecules for Innovative Medicines

Series B
85 employees
Biotechnology, Health Care
AlphaMa vs
SARomics Biostructures AB
SARomics Biostructures AB Sweden

Protein Crystallography & Integrated Drug Discovery: Fragment Screening & Fragment-Based Drug Design...

Series Unknown
31 employees
Biotechnology, Health Care

FAQ About AlphaMa

AlphaMa is a pioneering drug R&D company based on AI and DEL drug discovery innovation platform.
AlphaMa is headquartered in Suzhou, China.
AlphaMa has approximately 7 employees.
Top alternatives and competitors to AlphaMa include DyNAbind GmbH, HitGen Inc., SARomics Biostructures AB, LC Sciences, PharmaBlock Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AlphaMa and DyNAbind GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AlphaMa and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy